Besides TGF-β, previous studies identified that insulin-like growth factor-binding proteins (IGFBPs) were also clearly associated with IPF and of interest as new potential biomarkers for SSc-ILD33,34. The gene discussed is TGFB1; the disease is systemic sclerosis.